These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 37790630)
21. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases. Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836 [TBL] [Abstract][Full Text] [Related]
22. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma. Yang X; Wang G; Gu R; Xu X; Zhu G PeerJ; 2020; 8():e10418. PubMed ID: 33304656 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y Front Immunol; 2022; 13():950001. PubMed ID: 36091041 [TBL] [Abstract][Full Text] [Related]
24. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining. Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898 [TBL] [Abstract][Full Text] [Related]
25. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972 [TBL] [Abstract][Full Text] [Related]
26. Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification. Chen X; Zhao X; Li D; Zha W Curr Med Chem; 2024 Aug; ():. PubMed ID: 39108112 [TBL] [Abstract][Full Text] [Related]
27. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma. Wang S; Cai W; Li J; An W; Zheng H; Liao M Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964 [TBL] [Abstract][Full Text] [Related]
28. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ Front Oncol; 2022; 12():1022097. PubMed ID: 36300102 [TBL] [Abstract][Full Text] [Related]
30. Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H Front Oncol; 2023; 13():1274439. PubMed ID: 38152367 [TBL] [Abstract][Full Text] [Related]
31. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. Chen A; Ding S; Shen X; Lin X Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321 [TBL] [Abstract][Full Text] [Related]
32. Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation. Guo W; Zhao G; Liu S; Deng T; Zhang G; Zhang B J Gene Med; 2023 Sep; 25(9):e3534. PubMed ID: 37259225 [TBL] [Abstract][Full Text] [Related]
33. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis. Dodin Y Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325 [TBL] [Abstract][Full Text] [Related]
34. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
35. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
37. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
38. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
40. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]